Amount of Oral Formulations of Drugs for Carcinoma Used at 10 National University Dental Hospitals in Japan.
スポンサーリンク
概要
- 論文の詳細を見る
The total number of prescriptions and the total amount of oral drugs for carcinoma purchased at 10 national university dental hospitals in Japan were investigated. During the fiscal year, Apr. 1, 1995 to Mar. 31, 1996, the total number of prescriptions for ambulatory patients at the 10 hospitals was 101, 707. They included 2, 646 prescriptions of anticancer drugs, which was 2.06 % (2, 646/101, 707) of all prescriptions. The most prescribed drug for carcinoma at the 10 hospitals surveyed was UFT<SUP>®</SUP>, with 206, 975 × 100mg doses dispensed per year. A small amount of off-labeling drugs such as Ubenimex (Bestatin<SUP>®</SUP> ), PSK (Krestin<SUP>®</SUP> ), Tegafur (Fental<SUP>®</SUP> ), and Doxifluridine (Furtulon<SUP>®</SUP> ) was used at six hospitals.
- 日本歯科薬物療法学会の論文
日本歯科薬物療法学会 | 論文
- カンジダのバイオフィルム産生性に対する抗真菌薬の効果
- 当院における全身麻酔下手術中に使用された抗菌薬の15年間(1992-2006年)の推移
- 「顎骨骨髄炎に対する抗菌薬の効果判定基準」の解析結果
- 植物精油の口腔微生物に対する抗菌性およびバイオフィルム形成抑制効果の検討
- ニフェジピン歯肉増殖症患者の線維芽細胞に対する18α-グリチルレチン酸のアポトーシス誘導効果